Cell Impact AB (publ) reported consolidated and parent earnings results for the fourth quarter and full year ended December 31, 2020. For the quarter, on consolidated basis, the company reported net sales of SEK 8.9 million against SEK 2.0 million a year ago. Operating loss was SEK 12.3 million against SEK 16.9 million a year ago. Loss per share, attributable to the shareholders of the parent company was SEK 0.21 against SEK 0.37 a year ago. Loss attributable to the shareholders of the Parent Company was SEK 12.5 million against SEK 17.0 million a year ago. For the year, on consolidated basis, the company reported net sales of SEK 29.3 million against SEK 11.9 million a year ago. Operating loss was SEK 43.1 million against SEK 47.4 million a year ago. Loss per share, attributable to the shareholders of the parent company was SEK 0.88 against SEK 1.45 a year ago. Loss attributable to the shareholders of the Parent Company was SEK 44.3 million against SEK 48.4 million a year ago. For the quarter, on parent basis, the company reported net sales of SEK 8.9 million against SEK 2.0 million a year ago. Operating loss was SEK 12.4 million against SEK 16.9 million a year ago. Loss for the period was SEK 12.5 million against SEK 16.9 million a year ago. For the year, on parent basis, the company reported net sales of SEK 29.3 million against SEK 12.0 million a year ago. Operating loss was SEK 43.2 million against SEK 47.4 million a year ago. Loss for the period was SEK 43.3 million against SEK 48.3 million a year ago.